The Roche group achieved sales of CHF 15.143 billion ($15.6 billion) in the first quarter as demand for new products more than offset the impact of competition from biosimilar medicines. Sales at constant exchange rates were up by 7%. ---Subscribe to MedNous to access this article--- Company News
